CB
Claude Brown
Reed Smith
Partner
Presentation
Claude is a leading member of Reed Smith’s global derivatives practice and brings more than 26 years’ experience in the derivatives markets in Europe, North America, Asia, South America and Africa, both as a lawyer and as a banker. He practices in all aspects of derivatives, both OTC and exchange traded. He advises banks, funds and corporates on the structuring, documentation and regulation of interest rate, FX, credit, equity, commodity and exotic derivatives (including weather, catastrophe and economic variables). Claude also has an active practice in advising a range of clients on prime brokerage and related transactions, debt trading and market infrastructure issues. He is regularly involved in helping clients develop capital and regulatory efficient structures, as well as devising risk-mitigation techniques to assist in minimizing counterparty and market risk in complex and novel structures. As a recognized leading practitioner in derivative product development, he is frequently retained by clients to assist them in devising and developing new products both for their own use and as part of their client offerings. As a result, he has been involved in a number of market “firsts,” including the first weather derivative transaction in Europe, the first European and Australian synthetic securitizations, the first project finance synthetic securitization, the first sports derivatives in the UK, the first international registry for voluntary compliance emission allowances, and the first FX hedge for a securitization to comply with the new Russian derivatives laws. During his career he has worked on the derivative aspects of a number of landmark deals, including the financing of the Eurotunnel project, the construction of the London Olympic Village, the UK Thameslink railway line and rolling stock, the securitization of Canary Wharf, the UK Government’s Asset Protection Scheme, the restructuring of Russian Soviet era debt, the Russian and Asia financial crises, and the EBRDs derivative immunization program.
Loading